In the fact sheets on the country-specific framework conditions for the reimbursement of digital therapeutics (DTx), the Digital Therapeutics Alliance (DTA) lists Germany, France and the United Kingdom for Europe alongside the USA, China, Japan, Singapore, South Korea and Australia. The current landscapes of regulation and reimbursement for each country are listed in a grid in the fact sheets. In this way, the Digital Therapeutics Alliance aims to make it easier to identify similarities and differences for strategic approaches to patient access to clinically validated therapies. |